Thompson Rubinstein Investment Management’s West Pharmaceutical WST Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$431K	Hold	3,907	–	–	0.14%	70
2018 Q4	$383K	Hold	3,907	–	–	0.14%	70
2018 Q3	$482K	Hold	3,907	–	–	0.15%	67
2018 Q2	$388K	Hold	3,907	–	–	0.13%	71
2018 Q1	$345K	Hold	3,907	–	–	0.12%	73
2017 Q4	$386K	Sell	3,907 -93	-2%	-$9.12K	0.13%	71
2017 Q3	$385K	Hold	4,000	–	–	0.13%	70
2017 Q2	$378K	Hold	4,000	–	–	0.14%	74
2017 Q1	$326K	Hold	4,000	–	–	0.12%	76
2016 Q4	$339K	Hold	4,000	–	–	0.13%	71
2016 Q3	$298K	Hold	4,000	–	–	0.11%	72
2016 Q2	$304K	Hold	4,000	–	–	0.12%	75
2016 Q1	$277K	Hold	4,000	–	–	0.11%	74
2015 Q4	$241K	Hold	4,000	–	–	0.11%	74
2015 Q3	$216K	Hold	4,000	–	–	0.1%	73
2015 Q2	$232K	Hold	4,000	–	–	0.09%	73
2015 Q1	$241K	Hold	4,000	–	–	0.09%	71
2014 Q4	$213K	Buy	+4,000	New	+$200K	0.08%	73

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Thompson Rubinstein Investment Management's WST Position: Q1 2019 in Review

Thompson Rubinstein Investment Management held its West Pharmaceutical (WST) position steady in Q1 2019 at 3,907 shares worth $431K. The position accounts for 0.14% of the portfolio, ranked #70.

Thompson Rubinstein Investment Management first reported a position in WST in Q4 2014 and has held it in 18 quarters since. The position peaked at $482K in Q3 2018. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

Thompson Rubinstein Investment Management held 3,907 shares of West Pharmaceutical worth $431K as of Q1 2019.
Thompson Rubinstein Investment Management left its West Pharmaceutical share count unchanged in Q1 2019.
West Pharmaceutical made up 0.14% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #70 holding.
Thompson Rubinstein Investment Management first reported a position in West Pharmaceutical in Q4 2014 and has held it in 18 quarters since.
Thompson Rubinstein Investment Management's West Pharmaceutical position peaked at $482K in Q3 2018.
379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.